MedPharm Research

MedPharm is a private, active contract development and manufacturing organization focused on topical, transdermal, transepithelial, and mucosal drug products. Founded in 1999 from scientific roots at King’s College London, the company provides formulation development, analytical and bioanalytical testing, in vitro performance testing, clinical trial material supply, and commercial GMP manufacturing. Following its July 2024 merger with Tergus Pharma, MedPharm expanded into a more integrated end-to-end CDMO with major operations in Guildford, UK and Durham, North Carolina. The company serves pharmaceutical and biotech clients rather than primarily advancing a proprietary therapeutic pipeline, with notable expertise in semi-solid and liquid dosage forms, complex generics, new chemical entities, and patient-centric reformulations. MedPharm also highlights proprietary delivery and testing capabilities, including its MedSpray technology and research models designed to de-risk development and support regulatory submissions.